Volume 9, Issue 1 (4-2019)                   JABS 2019, 9(1): 1289-1300 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khodadadi I, Shafiee G. The Evaluation of the effects of cytotoxic, anti-proliferative and anti-migrative effects of the thymoquinone on PC3 prostate cancer cell line . JABS 2019; 9 (1) :1289-1300
URL: http://jabs.fums.ac.ir/article-1-1630-en.html
1- Department of Clinical Biochemistry, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
2- Department of Clinical Biochemistry, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran , g.r_shafiee@yahoo.com
Abstract:   (3754 Views)
Background & Objective: Herbal medicine and their composition are widely used for different therapeutic purposes. Therefore, this study was designed to evaluate of the anti-proliferation and anti-migration effects of Thymoquinone (TQ), an active part of Nigella sativa, on PC3 prostate cancer cells.
Materials & Methods: In this experimental study, PC3 prostate cancer cells were treated with 0, 10, 30, 50, 70 and 90 µM concentrations of thymoquinone for 12, 24 and 48 hours and cell viability was determined by MTT assay. IC50 concentration of thymoquinone was obtained as 40 µM concentration of thymoquinone and 24h incubation time. PC3 cell migration was studied using the cell migration assay. Colony formation assay was used to determine cell proliferation and Gimsa staining was performed to observe morphological changes of the cells.
Results: The IC50 of Thymoquinone was found in concentration of 40 µM at 24h treatment. Thymoquinone significantly (p<0.05) inhibited cell growth and proliferation as well as cell migration. Treatment of PC3 cells with 40 µM thymoquinone showed significant changes in nucleus and cytoplasm of the cells which are representative of apoptosis and cell death.
Conclusion: Thymoquinone has significant anti-proliferative and anti-migrative effects on prostate PC3 cells and therefore may be used as a complementary agent for prevention of prostate cancer.
 

 
Full-Text [PDF 1444 kb]   (2396 Downloads)    
Type of Study: Research | Subject: Biochemistry
Received: 2018/04/18 | Accepted: 2018/11/7 | Published: 2019/06/8

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advanced Biomedical Sciences

Designed & Developed by: Yektaweb

Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)